Absence of respiratory effects with ivabradine in patients with asthma

British Journal of Clinical Pharmacology

Volumn 66, Issue 1, 2008, Pages 96-101

  Babu, K Suresh ^a   Gadzik, Frantisek ^b   Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Adrenergic antagonists; Angina pectoris; Asthma; Bronchoconstriction; Ivabradine; Respiratory function

Indexed keywords

BECLOMETASONE; IVABRADINE; PLACEBO; SALBUTAMOL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG WITHDRAWAL; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HEART RATE; HUMAN; LEG PAIN; MALE; MORNING DOSAGE; NAUSEA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SYMPTOMATOLOGY; THORAX PAIN; VISUAL DISORDER; VOMITING;

ADOLESCENT; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; BENZAZEPINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 44449088566     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03160.x     Document Type: Article

References (21)

1. Daly CA, Clemens F, Sendon JL, Tavazzi L, Boersma E, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM on behalf of the Euro Heart Survey Investigators. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina. Eur Heart J 2005 26 : 996 1010.
2. Staniforth AD. Contemporary management of chronic stable angina. Drugs Aging 2001 18 : 109 21.
3. Fihn SD, Williams SV, Daley J, Gibbons RJ. Guidelines for the management of patients with chronic stable angina: treatment. Ann Intern Med 2001 135 (8 Pt 1 616 32.
4. Devereux G, Fishwick K, Aiken TC, Bourke SJ, Hendrick DJ. Adverse effects of a single dose of (+)-sotalol in patients with mild stable asthma. Br J Clin Pharmacol 1998 46 : 79 82.
5. Dart RA, Gollub S, Lazar J, Nair C, Schroeder D, Woolf SH. Treatment of systemic hypertension in patients with pulmonary disease: COPD asthma. Chest 2003 123 : 222 43.
6. Raine JM, Palazzo MG, Kerr JH, Sleight P. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane. Br Med J (Clin Res Ed) 1981 282 : 548 9.
7. Bois P, Bescond J, Renaudon B, Lenfant J. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996 118 : 1051 7.
8. Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D 2003 4 : 83 9.
9. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004 64 : 1757 65.
10. National Institute of Health. Global Strategy for Asthma Management and Prevention : 2002. Report no. 02-3659.
11. Asirvatham S, Sebastian C, Thadani U. Choosing the most appropriate treatment for stable angina. Safety considerations. Drug Saf 1998 19 : 23 44.
12. Tafreshi MJ, Weinacker AB. Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma. Pharmacotherapy 1999 19 : 974 8.
13. Greefhorst AP, van Herwaarden CL. Comparative study of the ventilatory effects of three beta 1-selective blocking agents in asthmatic patients. Eur J Clin Pharmacol 1981 20 : 417 21.
14. Fujimura M, Abo M, Kamio Y, Myou S, Ishiura Y, Hashimoto T, Matsuda T. Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction. Am J Respir Crit Care Med 1999 160 : 2100 3.
15. Fallowfield JM, Marlow HF. Propranolol is contraindicated in asthma. BMJ 1996 313 : 1486.
16. Spitz DJ. An unusual death in an asthmatic patient. Am J Forensic Med Pathol 2003 24 : 271 2.
17. Soriano JB, Kiri VA, Maier WC, Strachan D. Increasing prevalence of asthma in UK primary care during the 1990s. Int J Tuberc Lung Dis 2003 7 : 415 21.
18. European Respiratory Society. European Lung White Book. Lausanne, Switzerland : European Respiratory Society, 2003 35 42.
19. Suissa S, Assimes T, Brassard P, Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med 2003 115 : 377 81.
20. Manz M, Reuter M, Lauck G, Omran H, Jung W. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology 2003 100 : 149 55.
21. Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003 107 : 817 23.